What is a quantum computer good for? Absolutely nothing — yet

The piece notes that no quantum computer has yet completed a conclusively useful commercial task, despite renewed optimism. On June 22, Donald Trump’s science adviser promised a quantum computer powerful enough for scientific discovery by 2028, alongside a new executive order aimed at speeding U.S. quantum computing versus China. It also cites Microsoft’s June announcement of a new quantum chip, “Majorana 2,” described as a hardware advancement, though the article frames the broader outlook as largely hype relative to current capabilities.

Analysis

This is a sentiment event, not a fundamental inflection. The market mechanism is a lower cost of capital for quantum-adjacent equities and a temporary halo for incumbents that can frame quantum as a long-dated option on platform relevance. The only names with durable upside are the ones that can absorb years of R&D without needing near-term monetization; that favors MSFT far more than small-cap pure plays.

The second-order loser is the speculative quantum complex: policy attention can lift multiples faster than technical progress, but it also raises dilution risk because most of these businesses still need external funding before any economic use case appears. If enthusiasm fades or the next milestone slips, the drawdown can be sharp because there is no cash-flow floor underwriting the valuation.

Contrarianly, the consensus is overestimating how much geopolitics accelerates commercialization. Export controls and federal rhetoric may increase bidding activity and grant headlines, but the real bottleneck is error correction and scale, which is measured in quarters/years, not campaign cycles. The key falsifiers are: no increase in funded pilots or federal awards over 1-2 quarters, or management updates that keep pushing useful quantum further out; without that, this remains a trading tape, not a growth regime.

DJT is mostly a reflexive political-beta name here; unless there is a direct policy transmission mechanism, any move should be treated as noise and likely mean-reverting.

Key Decisions for Investors

• Long MSFT / short QUBT as a 1-3 month pair trade on quantum-policy hype: MSFT gets paid for optionality with no balance-sheet strain, while QUBT is exposed to valuation compression if technical milestones lag or financing risk reappears. Tighten if QUBT secures a material federal contract or strategic capital raise.
• Do not chase DJT on this headline; any sympathy pop should be faded over days unless there is an explicit policy linkage to monetizable business value. If already long, use strength to trim.
• Treat pure-play quantum names as a watchlist only until there is verifiable funding or procurement data; absent that, the risk/reward is skewed toward dilution-driven downside over the next 1-2 quarters.
• If MSFT sells off on broader tech weakness, use that weakness to add only if you want a long-duration option on quantum; do not pay up solely for the quantum narrative because it is unlikely to move near-term earnings.